Are H1-Antihistamines Associated With a Lower Risk of Hepatocellular Carcinoma?

J Clin Oncol. 2022 Jul 20;40(21):2389-2390. doi: 10.1200/JCO.22.00179. Epub 2022 May 12.

Authors

Cho-Han Chiang¹, Cho-Hsien Chiang¹, Cho-Hung Chiang¹

Affiliation

¹ Cho-Han Chiang, MD, Harvard Medical School, Boston, MA; Cho-Hsien Chiang, MD, London School of Hygiene & Tropical Medicine, London, UK; and Cho-Hung Chiang, MD, Division of General Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Foundation, New Taipei City, Taiwan.

PMID: 35549455
DOI: 10.1200/JCO.22.00179

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular*
Histamine H1 Antagonists
Humans
Liver Neoplasms*

Substances

Histamine H1 Antagonists